This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Souhail Delassan: Innovator in Polysaccharide Composition
Introduction
Souhail Delassan is a notable inventor based in Gaillard, France. He has made significant contributions to the field of polysaccharide compositions, particularly in the area of imaging technologies. His innovative work has led to the development of a unique compound that has potential applications in various scientific fields.
Latest Patents
Delassan holds a patent for a "Partially delipidated D25 polysaccharide composition for imaging." This invention relates to a D25 polysaccharide compound from which lipids have been partially removed. The compound is characterized by at least 85% by weight, preferably 90%, existing in aqueous solution in monomeric form. The polysaccharide compound, with a molecular weight of 30 kD, is extracted from the membrane proteoglycan of the bacterium Klebsiella pneumoniae. Notably, the amount of palmitic fatty acids bound to it in esterified form does not exceed 0.01% by weight, and the amount associated in free form does not exceed 0.1% by weight.
Career Highlights
Delassan is currently associated with Pierre Fabre Medicament, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding and application of polysaccharide compounds in medical and imaging technologies.
Collaborations
Throughout his career, Delassan has collaborated with esteemed colleagues such as Hans Binz and Lucien Dussourd d'Hinterland. These collaborations have fostered a rich exchange of ideas and innovations in the field.
Conclusion
Souhail Delassan's contributions to the field of polysaccharide compositions exemplify the impact of innovative research on scientific advancements. His patent and ongoing work at Pierre Fabre Medicament highlight the importance of collaboration and creativity in driving progress in technology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
